Caregiver acceptance of adverse effects and use of cholinesterase inhibitors in Alzheimer's disease

Canadian Journal on Aging

Volumn 26, Issue 3, 2007, Pages 205-212

  Oremus, Mark ^a,b,d   Wolfson, Christina ^a,b   Vandal, Alain C ^a,b   Bergman, Howard ^a,c   Xie, Qihao ^d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Adverse effects; Aging; Alzheimer's disease; Caregiver; Cholinesterase inhibitors

Indexed keywords

CHOLINESTERASE INHIBITOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CAREGIVER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK BENEFIT ANALYSIS;

AGING; ALZHEIMER DISEASE; APPETITE; CAREGIVERS; CHOLINESTERASE INHIBITORS; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; QUEBEC; QUESTIONNAIRES; RISK ASSESSMENT; WEIGHT LOSS;

EID: 39449083881     PISSN: 07149808     EISSN: 17101107     Source Type: Journal    
DOI: 10.3138/cja.26.3.205     Document Type: Article

References (10)

1. Karlawish JH, Casarett D, Propert KJ, James BD, Clark CM. Relationship between Alzheimer's disease severity and patient participation in decisions about their medical care. J Geriatr Psychiatry Neurol 2002;15;68-72.
2. Gauthier S. Advances in the pharmacotherapy of Alzheimer's disease. Can Med Assoc J 2002;166;616-623.
3. Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, et al. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technol Assess 2006;10;1-160.
4. Karlawish JH, Casarett DJ, James BD, Tenhave T, Clark CM, Asch DA. Why would caregivers not want to treat their relative's Alzheimer's disease? J Am Geriatr Soc 2003;51;1391-1397.
5. Karlawish JH, Klocinski JL, Merz J, Clark CM, Asch DA. Caregivers' preferences for the treatment of patients with Alzheimer's disease. Neurology 2000;55;1008-1014.
6. Oremus M, Cosby JL, Wolfson C. A hybrid qualitative method for pretesting questionnaires: the example of a questionnaire to caregivers of Alzheimer disease patients. Res Nurs Health 2005;28;419-430.
7. Dillman DA. Mail and Internet surveys: the tailored design method. 2 ed. New York: Wiley; 2000.
8. Lanctôt KL, Herrmann N, Yau KK, Khan LR, Liu BA, LouLou MM, et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. Can Med Assoc J 2003;169;557-564.
9. Hosmer DW, Lemeshow S. Applied logistic regression. 2 ed. New York: Wiley; 2000.
10. Gardner W, Mulvey EP, Shaw EC. Regression analysis of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull 1985;118;392-404.